Patients with ESD-derived artificial ulcers were randomly assigned to two groups : a group of patients who received rabeprazole @ mg daily for @ weeks ( PPI group ) and a group of patients who received a combination of rebamipide @ mg daily for @ weeks and rabeprazole @ mg dairy for the first @ weeks ( reb + PPI group ) .